William Blair Investment Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

William Blair Investment Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-49,211	Closed	-$6.13M	–	468
2016 Q3	$6.13M	Buy	49,211 +43,822	+813%	+$5.17M	0.02%	343
2016 Q2	$573K	Sell	5,389 -209,364	-97%	-$24.3M	﹤0.01%	432
2016 Q1	$24.6M	Sell	214,753 -60,682	-22%	-$7.12M	0.1%	182
2015 Q4	$39.2M	Buy	275,435 +173,090	+169%	+$20M	0.16%	150
2015 Q3	$9.19M	Buy	+102,345	New	+$10.8M	0.02%	708

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

William Blair Investment Management's CBPO Position: Q4 2016 in Review

William Blair Investment Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2016, closing a stake of 49,211 shares — an estimated $6.13M sold.

William Blair Investment Management first reported a position in CBPO in Q3 2015 and held it in 5 quarters. The position peaked at $39.2M in Q4 2015. 143 funds tracked by Wall St. Rank hold CBPO as of Q4 2016.

William Blair Investment Management reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2016 after selling out during the quarter.
William Blair Investment Management sold 49,211 China Biologic Products Holdings, Inc. shares in Q4 2016, an estimated $6.13M.
William Blair Investment Management first reported a position in China Biologic Products Holdings, Inc. in Q3 2015 and held it in 5 quarters.
William Blair Investment Management's China Biologic Products Holdings, Inc. position peaked at $39.2M in Q4 2015.
143 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2016.

Based on William Blair Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.